跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-43
首页
药物
M-43
M-43
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TDP-43 AGGREGATION INHIBITOR
EP 3831942 A4
申请人: UNIV NAT CORP TOKYO MEDICAL & DENTAL
优先权: 2018
EP
US
WO
3 件公开
OPHTHALMIC FORMULATION AND ITS USE
EP 4125819 A1
申请人: OY FINNSUSP AB
优先权: 2020
EP
WO
3 件公开
Thrombin Derivatives And Medicinal Composition Containing The Same
US 2007282095 A1
申请人: HOSOKAWA KAZUYA
优先权: 2004
CN
US
2 件公开
OIL-IN-WATER EMULSION COSMETIC
EP 4670707 A1
申请人: KAO CORP
优先权: 2023
CN
EP
2 件公开
Cyanine dye having multifunctional peripreral groups
US 2006030705 A1
申请人: SILVERBROOK RES PTY LTD
优先权: 2004
US
2 件公开
Gaussia luciferase variant for high-throughput screening
US 8980603 B2
申请人: TANNOUS BAKHOS A
优先权: 2010
US
2 件公开
Indolinones substituted in six locations, their manufacture and their application as medicine
EP 2157081 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2000
EP
The use of substituted carbocyclic compounds as rotamases inhibitors
EP 1402888 A1
申请人: JERINI AG
优先权: 2002
EP
Benzo¬a pyrano¬3,2-h acridin-7-one derivatives, processes for their preparation and pharmaceutical compositions thereof
EP 1491544 A1
申请人: SERVIER LAB
优先权: 2003
EP
5,6 substituted benzamide derivatives as modulators of EP2 receptors
EP 2149552 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2008
EP
第 1 / 3 页
上一页
下一页
药物
反馈